Search
What you need to know before registering a company in the UAE
Company Registration
Banking Solutions in the UAE & Oman
Corporate Compliance & Reporting
Annual Corporate Maintenance Services in the UAE
Legal & Corporate Support Services
Business Acquisition & Ready-Made Companies in the UAE
Corporate Legal Services in the UAE
Business Partnerships & Joint Ventures in the UAE
Types of companies in the UAE. Types of activities
UAE Visas
Government Bodies. What Issues They Address
Types of Legal Entities
Licensing
What you need to know before registering a company in the UAE
Company Registration
Banking Solutions in the UAE & Oman
Corporate Compliance & Reporting
Annual Corporate Maintenance Services in the UAE
Legal & Corporate Support Services
Business Acquisition & Ready-Made Companies in the UAE
Corporate Legal Services in the UAE
Business Partnerships & Joint Ventures in the UAE
Types of companies in the UAE. Types of activities
UAE Visas
Government Bodies. What Issues They Address
Types of Legal Entities
Licensing
## Pioneering Genomics Trial in Abu Dhabi
The United Arab Emirates has launched its first clinical trial aimed at preventing Alzheimer's disease using genomics. This initiative, driven by the Emirati Genome Programme, is a collaboration between M42’s Insights Research Organization and Solutions (IROS), the Department of Health – Abu Dhabi, and Halia Therapeutics, a US-based biotech firm.
## Focus on Early Detection
The trial seeks to identify individuals at high risk for Alzheimer's before symptoms emerge by utilizing genomic data. Participants will be screened for the APOE4 gene variant, a significant genetic marker for late-onset Alzheimer's. This approach aims to shift healthcare towards prevention-focused strategies.
## Regulatory and Ethical Oversight
The Department of Health – Abu Dhabi is overseeing the trial, ensuring compliance with data protection and patient privacy regulations. Eligible participants will be invited for screening through targeted outreach efforts.
## Advancing Precision Medicine
Dr. Noura Al Ghaithi from the Department of Health highlighted the Emirati Genome Programme's role in transforming healthcare by integrating genomic data into clinical research. This trial exemplifies the UAE's commitment to personalized healthcare and early risk detection.
## Global Implications
Alzheimer’s disease affects over 55 million people worldwide, with numbers expected to rise significantly. The UAE's genomic resources, which include over 900,000 sequenced genomes, provide a robust foundation for advancing precision medicine and addressing global health challenges.
## Halia Therapeutics' Role
Halia Therapeutics is focusing on genetic resilience to develop therapies that enhance natural resistance to Alzheimer's. Their investigational therapy, HT-4253, targets pathways associated with the disease's progression, marking a significant step in prevention-focused neurological research.
## Abu Dhabi as a Biotech Hub...
Leave your details and get a guide as a gift to avoid mistakes
Share article